Stocks to Watch: Delta Air Lines, Oracle, LifeMD, Tenon Medical

Dow Jones
03-11
 

By Connor Hart

 

Delta Air Lines lowered its first-quarter outlook, citing reduced consumer and corporate confidence amid economic uncertainty. The airline now expects adjusted per-share earnings of 30 cents to 50 cents and for revenue to rise 3% to 4% from a year ago, compared with a prior outlook for adjusted per-share earnings of 70 cents to $1 and for revenue to rise 7% to 9%. Delta said that domestic travel is most heavily affected. Shares fall 11%, to $44.70, in after-hours trading.

Oracle's fiscal third-quarter results missed expectations, though the cloud-services offered an upbeat sales outlook as it aims to double its data center capacity this year. The company reported adjusted earnings of $1.47 a share on revenue of $14.13 billion, missing analyst forecasts for adjusted earnings of $1.49 a share on revenue of $14.38 billion. For the current quarter, Oracle expects revenue to grow 9% to 11%, with total cloud revenue jumping between 24% and 28%. Shares fall 3.4%, to $143.77, in postmarket trading.

LifeMD's fourth-quarter financial results topped analyst expectations. The telehealth company posted a per-share loss of 2 cents, ahead of the 7-cent loss that analysts modeled. Revenue of $64.3 million topped analyst views for $57.5 million. The company guided for sales of $265 million to $275 million in 2025, above the $258 million that analysts were looking for. Shares jump 25%, to $5.35, in after-hours trading.

Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation Device have been approved for grant of a European patent within the European Community. Shares rise 44%, to $1.80, in postmarket trading.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

March 10, 2025 19:31 ET (23:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10